Compound details
Gibberellin A12 7-aldehyde
| Compound ID | CDAMM00847 |
|---|---|
| Common name | Gibberellin A12 7-aldehyde | IUPAC name | 2-formyl-4,8-dimethyl-13-methylidenetetracyclo[10.2.1.01,9.03,8]pentadecane-4-carboxylic acid |
| Molecular formula | C20H28O3 |
| Retention time | 17.07 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 317.216 | Theoretical mz | 317.211 |
| Error | 13.63 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 7.4525 |
| Inchi key | ZCTUNYRXJKLWPY-UHFFFAOYNA-N |
|---|---|
| Smiles | O=CC1C2C(C(=O)O)(C)CCCC2(C)C3CCC4C(=C)CC13C4 |
| Superclass | Lipids and lipid-like molecules |
| Class | Prenol lipids |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P35228 | NOS2 | Nitric oxide synthase, inducible | T02703 | SwissTargetPrediction |
| Q07820 | MCL1 | Induced myeloid leukemia cell differentiation protein Mcl-1 | T14912 | SwissTargetPrediction |
| P12821 | ACE | Angiotensin-converting enzyme | T98311 | SwissTargetPrediction |
| P02766 | TTR | Transthyretin | T86462 | SwissTargetPrediction |
| Q96RI1 | NR1H4 | Bile acid receptor FXR | T51426 | SwissTargetPrediction |
| P08473 | MME | Neprilysin | T05409 | SwissTargetPrediction |
| P34913 | EPHX2 | Epoxide hydratase | T35734 | SwissTargetPrediction |
| P15121 | AKR1B1 | Aldose reductase | T26623 | SwissTargetPrediction |
| P35354 | PTGS2 | Cyclooxygenase-2 | T66665 | SwissTargetPrediction |
| P10275 | AR | Androgen Receptor | T11211 | SwissTargetPrediction |
| Q92731 | ESR2 | Estrogen receptor beta | T80896 | SwissTargetPrediction |
| O00519 | FAAH | Anandamide amidohydrolase | T11754 | SwissTargetPrediction |
| P07148 | FABP1 | Fatty acid-binding protein, liver (by homology) | T73712 | SwissTargetPrediction |
| P11511 | CYP19A1 | Cytochrome P450 19A1 | T13260 | SwissTargetPrediction |
| O14684 | PTGES | Prostaglandin E synthase | T02562 | SwissTargetPrediction |
| P29350 | PTPN6 | Protein-tyrosine phosphatase 1C | T98264 | SwissTargetPrediction |
| P18031 | PTPN1 | Protein-tyrosine phosphatase 1B | T16347 | SwissTargetPrediction |
| P17706 | PTPN2 | T-cell protein-tyrosine phosphatase | T49156 | SwissTargetPrediction |
| P15090 | FABP4 | Fatty acid binding protein adipocyte | T07217 | SwissTargetPrediction |
| Q07869 | PPARA | Peroxisome proliferator-activated receptor alpha | T86591 | SwissTargetPrediction |
| Q01469 | FABP5 | Fatty acid binding protein epidermal | T21507 | SwissTargetPrediction |
| P30307 | CDC25C | Dual specificity phosphatase Cdc25C | T40569 | SwissTargetPrediction |
| P28845 | HSD11B1 | 11-beta-hydroxysteroid dehydrogenase 1 | T65200 | SwissTargetPrediction |
| P11473 | VDR | Vitamin D receptor | T34234 | SwissTargetPrediction |
| Q8TDU6 | GPBAR1 | G-protein coupled bile acid receptor 1 | T86273 | SwissTargetPrediction |
| P06746 | POLB | DNA polymerase beta (by homology) | T06958 | SwissTargetPrediction |
| P08253 | MMP2 | Matrix metalloproteinase 2 | T68251 | SwissTargetPrediction |
| P22894 | MMP8 | Matrix metalloproteinase 8 | T08856 | SwissTargetPrediction |
| P14780 | MMP9 | Matrix metalloproteinase 9 | T54156 | SwissTargetPrediction |
| P16662 | UGT2B7 | UDP-glucuronosyltransferase 2B7 | T62815 | SwissTargetPrediction and SEA |
| Q13133 | NR1H3 | LXR-alpha | T52297 | SEA |
| P14174 | MIF | Macrophage migration inhibitory factor | T39977 | SwissTargetPrediction |
| P10827 | THRA | Thyroid hormone receptor alpha | T79591 | SwissTargetPrediction |
| P10828 | THRB | Thyroid hormone receptor beta-1 | T98933 | SwissTargetPrediction |
| P45452 | MMP13 | Matrix metalloproteinase 13 | T34296 | SwissTargetPrediction |
| P23946 | CMA1 | Chymase | T05114 | SwissTargetPrediction |
| P37231 | PPARG | Peroxisome proliferator-activated receptor gamma | T58921 | SwissTargetPrediction |
| O14746 | TERT | Telomerase reverse transcriptase | T86052 | SwissTargetPrediction |
| O00767 | SCD | Acyl-CoA desaturase | T10897 | SwissTargetPrediction |
| P48147 | PREP | Prolyl endopeptidase | T86161 | SwissTargetPrediction |
| P43116 | PTGER2 | Prostanoid EP2 receptor | T38529 | SwissTargetPrediction |
| Q96S37 | SLC22A12 | Solute carrier family 22 member 12 | T86057 | SwissTargetPrediction |
| Q9Y5Y4 | PTGDR2 | G protein-coupled receptor 44 | T61722 | SwissTargetPrediction |
| P49356 | FNTB | Farnesyl protein transferase | T13127 | SwissTargetPrediction |
| P11413 | G6PD | Glucose-6-phosphate 1-dehydrogenase | T63484 | SwissTargetPrediction |
| P11388 | TOP2A | DNA topoisomerase II alpha | T17048 | SwissTargetPrediction |
| P13500 | CCL2 | C-C motif chemokine 2 | T89988 | SwissTargetPrediction |
| P10276 | RARA | Retinoic acid receptor alpha | T94085 | SwissTargetPrediction |
| P30556 | AGTR1 | Type-1 angiotensin II receptor | T74456 | SwissTargetPrediction |
| P29375 | KDM5A | Lysine-specific demethylase 5A | T28052 | SwissTargetPrediction |
| P42892 | ECE1 | Endothelin-converting enzyme 1 | T50970 | SwissTargetPrediction |
| Q9UGL1 | KDM5B | Lysine-specific demethylase 5B | T56871 | SwissTargetPrediction |
| P05556 | ITGB1 | Integrin alpha2/beta1 | T01851 | SwissTargetPrediction |
| P23109 | AMPD1 | AMP deaminase 1 | T84553 | SwissTargetPrediction |
| P25101 | EDNRA | Endothelin receptor ET-A | T23499 | SwissTargetPrediction |
| P10619 | CTSA | Lysosomal protective protein | T37154 | SwissTargetPrediction |
| O43174 | CYP26A1 | Cytochrome P450 26A1 | T84634 | SwissTargetPrediction |
| P50052 | AGTR2 | Angiotensin II receptor | T09909 | SwissTargetPrediction |
| Q9H7Z7 | PTGES2 | Prostaglandin E synthase 2 | T01037 | SwissTargetPrediction |
| Q8TDS5 | OXER1 | Oxoeicosanoid receptor 1 | T68834 | SwissTargetPrediction |
| Q00987 | MDM2 | p53-binding protein Mdm-2 | T00176 | SwissTargetPrediction |
| P19793 | RXRA | Retinoid X receptor alpha (by homology) | T13726 | SwissTargetPrediction |
| P30307 | CDC25C | Dual specificity phosphatase Cdc25C | T40569 | SwissTargetPrediction |
| P10415 | BCL2 | Apoptosis regulator Bcl-2 | T31309 | SwissTargetPrediction |
| P13631 | RARG | Retinoic acid receptor gamma | T82146 | SwissTargetPrediction |
| P10826 | RARB | Retinoic acid receptor beta | T61657 | SwissTargetPrediction |
| P55055 | NR1H2 | LXR-beta | T13714 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T02703 | DI0083 | Chronic kidney disease | [ICD-11: GB61] | P35228 | NOS2 |
| T02703 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P35228 | NOS2 |
| T02703 | DI0375 | Sepsis | [ICD-11: 1G40-1G41] | P35228 | NOS2 |
| T02703 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P35228 | NOS2 |
| T14912 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | Q07820 | MCL1 |
| T14912 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | Q07820 | MCL1 |
| T14912 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | Q07820 | MCL1 |
| T14912 | DI0252 | Melanoma | [ICD-11: 2C30] | Q07820 | MCL1 |
| T14912 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | Q07820 | MCL1 |
| T14912 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q07820 | MCL1 |
| T98311 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P12821 | ACE |
| T98311 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P12821 | ACE |
| T86462 | DI0026 | Amyloidosis | [ICD-11: 5D00] | P02766 | TTR |
| T51426 | DI0043 | Autoimmune liver disease | [ICD-11: DB96] | Q96RI1 | NR1H4 |
| T51426 | DI0077 | Cholelithiasis | [ICD-11: DC11] | Q96RI1 | NR1H4 |
| T51426 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | Q96RI1 | NR1H4 |
| T05409 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P08473 | MME |
| T35734 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P34913 | EPHX2 |
| T35734 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P34913 | EPHX2 |
| T26623 | DI0298 | Neuropathy | [ICD-11: 8C0Z] | P15121 | AKR1B1 |
| T26623 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P15121 | AKR1B1 |
| T66665 | DI0087 | Chronic pain | [ICD-11: MG30] | P35354 | PTGS2 |
| T66665 | DI0145 | Female pelvic pain | [ICD-11: GA34] | P35354 | PTGS2 |
| T66665 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | P35354 | PTGS2 |
| T66665 | DI0207 | Indeterminate colitis | [ICD-11: DD72] | P35354 | PTGS2 |
| T66665 | DI0227 | Knee osteoarthritis | [ICD-11: FA01] | P35354 | PTGS2 |
| T66665 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P35354 | PTGS2 |
| T66665 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P35354 | PTGS2 |
| T66665 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P35354 | PTGS2 |
| T66665 | DI0416 | Tuberculosis | [ICD-11: 1B10-1B12] | P35354 | PTGS2 |
| T11211 | DI0005 | Acne vulgaris | [ICD-11: ED80] | P10275 | AR |
| T11211 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P10275 | AR |
| T11211 | DI0021 | Alcoholic liver disease | [ICD-11: DB94] | P10275 | AR |
| T11211 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P10275 | AR |
| T11211 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P10275 | AR |
| T11211 | DI0145 | Female pelvic pain | [ICD-11: GA34] | P10275 | AR |
| T11211 | DI0194 | Hypo-osmolality/hyponatraemia | [ICD-11: 5C72] | P10275 | AR |
| T11211 | DI0237 | Low bone mass disorder | [ICD-11: FB83] | P10275 | AR |
| T11211 | DI0247 | Mammary tumour | [ICD-11: 2C60-2C6Z] | P10275 | AR |
| T11211 | DI0346 | Prostate cancer | [ICD-11: 2C82] | P10275 | AR |
| T11211 | DI0401 | Testicular dysfunction | [ICD-11: 5A81] | P10275 | AR |
| T80896 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q92731 | ESR2 |
| T80896 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | Q92731 | ESR2 |
| T80896 | DI0254 | Menopausal disorder | [ICD-11: GA30] | Q92731 | ESR2 |
| T80896 | DI0432 | Vasomotor/allergic rhinitis | [ICD-11: CA08] | Q92731 | ESR2 |
| T11754 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | O00519 | FAAH |
| T73712 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P07148 | FABP1 |
| T13260 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P11511 | CYP19A1 |
| T13260 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P11511 | CYP19A1 |
| T02562 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | O14684 | PTGES |
| T16347 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P18031 | PTPN1 |
| T16347 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P18031 | PTPN1 |
| T16347 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P18031 | PTPN1 |
| T16347 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P18031 | PTPN1 |
| T49156 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P17706 | PTPN2 |
| T86591 | DI0187 | Hyperlipidemia | [ICD-11: 5C80] | Q07869 | PPARA |
| T86591 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | Q07869 | PPARA |
| T86591 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | Q07869 | PPARA |
| T65200 | DI0210 | Influenza | [ICD-11: 1E30-1E32] | P28845 | HSD11B1 |
| T65200 | DI0239 | Lupus erythematosus | [ICD-11: 4A40] | P28845 | HSD11B1 |
| T65200 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P28845 | HSD11B1 |
| T34234 | DI0083 | Chronic kidney disease | [ICD-11: GB61] | P11473 | VDR |
| T34234 | DI0171 | Hair/hair growth developmental defect | [ICD-11: LC30] | P11473 | VDR |
| T34234 | DI0189 | Hyper-parathyroidism | [ICD-11: 5A51] | P11473 | VDR |
| T34234 | DI0195 | Hypo-parathyroidism | [ICD-11: 5A50] | P11473 | VDR |
| T34234 | DI0266 | Mineral deficiency | [ICD-11: 5B5K] | P11473 | VDR |
| T34234 | DI0351 | Psoriasis | [ICD-11: EA90] | P11473 | VDR |
| T34234 | DI0437 | Vitamin deficiency | [ICD-11: 5B55-5B5F] | P11473 | VDR |
| T86273 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | Q8TDU6 | GPBAR1 |
| T06958 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P06746 | POLB |
| T68251 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08253 | MMP2 |
| T08856 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P22894 | MMP8 |
| T54156 | DI0219 | Ischaemic/haemorrhagic stroke | [ICD-11: 8B20] | P14780 | MMP9 |
| T54156 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P14780 | MMP9 |
| T54156 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P14780 | MMP9 |
| T54156 | DI0419 | Ulcerative colitis | [ICD-11: DD71] | P14780 | MMP9 |
| T52297 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | Q13133 | NR1H3 |
| T39977 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P14174 | MIF |
| T79591 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | P10827 | THRA |
| T79591 | DI0197 | Hypo-thyroidism | [ICD-11: 5A00] | P10827 | THRA |
| T98933 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | P10828 | THRB |
| T34296 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P45452 | MMP13 |
| T05114 | DI0039 | Atopic eczema | [ICD-11: EA80] | P23946 | CMA1 |
| T05114 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P23946 | CMA1 |
| T05114 | DI0169 | Gram-positive bacterial infection | [ICD-11: 1B74-1F40] | P23946 | CMA1 |
| T05114 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P23946 | CMA1 |
| T05114 | DI0229 | Left ventricular failure | [ICD-11: BD11] | P23946 | CMA1 |
| T05114 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P23946 | CMA1 |
| T58921 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P37231 | PPARG |
| T58921 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P37231 | PPARG |
| T58921 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P37231 | PPARG |
| T86052 | DI0184 | Human immunodeficiency virus disease | [ICD-11: 1C60-1C62] | O14746 | TERT |
| T86052 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | O14746 | TERT |
| T86052 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | O14746 | TERT |
| T10897 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | O00767 | SCD |
| T86161 | DI0092 | Coeliac disease | [ICD-11: DA95] | P48147 | PREP |
| T86161 | DI0210 | Influenza | [ICD-11: 1E30-1E32] | P48147 | PREP |
| T86161 | DI0238 | Lung cancer | [ICD-11: 2C25] | P48147 | PREP |
| T86161 | DI0265 | Mild neurocognitive disorder | [ICD-11: 6D71] | P48147 | PREP |
| T38529 | DI0003 | Abortion | [ICD-11: JA00] | P43116 | PTGER2 |
| T38529 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | P43116 | PTGER2 |
| T38529 | DI0121 | Diabetic foot ulcer | [ICD-11: BD54] | P43116 | PTGER2 |
| T38529 | DI0166 | Glaucoma | [ICD-11: 9C61] | P43116 | PTGER2 |
| T38529 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P43116 | PTGER2 |
| T38529 | DI0378 | Sexual dysfunction | [ICD-11: HA00-HA01] | P43116 | PTGER2 |
| T38529 | DI0413 | Transplant rejection | [ICD-11: NE84] | P43116 | PTGER2 |
| T86057 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q96S37 | SLC22A12 |
| T61722 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | Q9Y5Y4 | PTGDR2 |
| T13127 | DI0342 | Premature ageing appearance | [ICD-11: LD2B] | P49356 | FNTB |
| T63484 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P11413 | G6PD |
| T17048 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P11388 | TOP2A |
| T17048 | DI0225 | Kaposi sarcoma | [ICD-11: 2B57] | P11388 | TOP2A |
| T17048 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P11388 | TOP2A |
| T89988 | DI0083 | Chronic kidney disease | [ICD-11: GB61] | P13500 | CCL2 |
| T89988 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P13500 | CCL2 |
| T89988 | DI0087 | Chronic pain | [ICD-11: MG30] | P13500 | CCL2 |
| T89988 | DI0184 | Human immunodeficiency virus disease | [ICD-11: 1C60-1C62] | P13500 | CCL2 |
| T89988 | DI0252 | Melanoma | [ICD-11: 2C30] | P13500 | CCL2 |
| T89988 | DI0262 | Metastatic tumour | [ICD-11: 2D50-2E2Z] | P13500 | CCL2 |
| T89988 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P13500 | CCL2 |
| T89988 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | P13500 | CCL2 |
| T89988 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P13500 | CCL2 |
| T89988 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P13500 | CCL2 |
| T94085 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P10276 | RARA |
| T94085 | DI0251 | Mature T-cell lymphoma | [ICD-11: 2A90] | P10276 | RARA |
| T74456 | DI0137 | Essential hypertension | [ICD-11: BA00] | P30556 | AGTR1 |
| T74456 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P30556 | AGTR1 |
| T74456 | DI0373 | Secondary hypertension | [ICD-11: BA04] | P30556 | AGTR1 |
| T74456 | DI0425 | Urinary system clinical symptom | [ICD-11: MF8Y] | P30556 | AGTR1 |
| T01851 | DI0060 | Brain cancer | [ICD-11: 2A00] | P05556 | ITGB1 |
| T01851 | DI0238 | Lung cancer | [ICD-11: 2C25] | P05556 | ITGB1 |
| T01851 | DI0365 | Retinopathy | [ICD-11: 9B71] | P05556 | ITGB1 |
| T23499 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P25101 | EDNRA |
| T23499 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P25101 | EDNRA |
| T23499 | DI0425 | Urinary system clinical symptom | [ICD-11: MF8Y] | P25101 | EDNRA |
| T37154 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P10619 | CTSA |
| T84634 | DI0314 | Oesophagitis | [ICD-11: DA24] | O43174 | CYP26A1 |
| T09909 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P50052 | AGTR2 |
| T09909 | DI0373 | Secondary hypertension | [ICD-11: BA04] | P50052 | AGTR2 |
| T00176 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | Q00987 | MDM2 |
| T00176 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q00987 | MDM2 |
| T13726 | DI0225 | Kaposi sarcoma | [ICD-11: 2B57] | P19793 | RXRA |
| T13726 | DI0283 | Mycosis fungoides | [ICD-11: 2B01] | P19793 | RXRA |
| T31309 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P10415 | BCL2 |
| T31309 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | P10415 | BCL2 |
| T31309 | DI0273 | Motor neuron disease | [ICD-11: 8B60] | P10415 | BCL2 |
| T31309 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P10415 | BCL2 |
| T82146 | DI0005 | Acne vulgaris | [ICD-11: ED80] | P13631 | RARG |
| T82146 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P13631 | RARG |
| T82146 | DI0225 | Kaposi sarcoma | [ICD-11: 2B57] | P13631 | RARG |
| T82146 | DI0277 | Muscle calcification/ossification | [ICD-11: FB31] | P13631 | RARG |
| T82146 | DI0351 | Psoriasis | [ICD-11: EA90] | P13631 | RARG |
| T61657 | DI0225 | Kaposi sarcoma | [ICD-11: 2B57] | P10826 | RARB |
| T13714 | DI0039 | Atopic eczema | [ICD-11: EA80] | P55055 | NR1H2 |